Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus

Elderly patients with diabetes are at high risk of polypharmacy because of multiple coexisting diseases and syndromes. Polypharmacy increases the risk of drug–drug and drug–disease interactions in these patients, who may already have age-related sensory and cognitive deficits; such deficits may dela...

Descripción completa

Detalles Bibliográficos
Autores principales: Onoviran, Olusola F., Li, Dongming, Toombs Smith, Sarah, Raji, Mukaila A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628533/
https://www.ncbi.nlm.nih.gov/pubmed/31321014
http://dx.doi.org/10.1177/2040622319862691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628533/
https://www.ncbi.nlm.nih.gov/pubmed/31321014
http://dx.doi.org/10.1177/2040622319862691

Ejemplares similares